Breast cancer in African American women: Epidemiology and tumor biology

Breast Cancer Research and Treatment

Volumn 40, Issue 1, 1996, Pages 11-24

  Trock, Bruce J ^a  

^a GEORGETOWN UNIVERSITY   (United States)

Author keywords

CYP1A1; erbB 2; Estrogen receptor; Molecular markers; p53; Risk factors

Indexed keywords

ESTROGEN RECEPTOR; PROTEIN P53;

BREAST CANCER; CANCER INCIDENCE; CANCER RISK; CANCER SURVIVAL; CAUCASIAN; FEMALE; HUMAN; MOLECULAR BIOLOGY; NEGRO; PATHOLOGY; PRIORITY JOURNAL; RACE DIFFERENCE; REVIEW;

EID: 0029812537     PISSN: 01676806     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF01805999     Document Type: Review

References (78)

1. Miller BA, Ries LAG, et al: SEER Cancer Statistics Review 1973-1990. NIH Publication No. 93-2789, U.S. Department of Health and Human Services, Bethesda, 1993
2. Gray GE, Henderson BE, Pike MC: Changing ratio of breast cancer incidence rates with age of black females compared with white females in the United States. J Natl Cancer Inst 64:461-463, 1980
3. Horm JW, Asire AJ, et al: SEER Program: Cancer Incidence and Mortality in the United States 1973-81. NIH Publication No. 85-1837, U.S. Department of Health and Human Services, Bethesda, 1984
4. Pickle LW, Mason TJ, et al: Atlas of U.S. cancer mortality among whites: 1950-1980. USDHHS Publication No. (NIH) 87-2900, Washington, 1987
5. Pickle LW, Mason TJ, et al: Atlas of U.S. cancer mortality among nonwhites: 1950-1980. USDHHS Publication No. (NIH) 90-1582, Washington, 1990
6. Sondik EJ, Edwards BK, et al: Cancer Statistics Review 1973-1986. NIH Publication No. 89-2789, U.S. Department of Health and Human Services, Bethesda, 1989
7. Ries LAG, Miller BA, et al: SEER Cancer Statistics Review 1973-1991. NIH Publication No. 94-2789, U.S. Department of Health and Human Services, Bethesda, 1994
8. Feuer EJ, Wun LM, et al: The lifetime risk of developing breast cancer. J Natl Cancer Inst 85:892-897, 1993
9. Devesa SS, Diamond EL: Association of breast cancer and cervical cancer incidence with income and education among whites and blacks. J Natl Cancer Inst 65:515-528, 1980
10. Austin H, Cole P, Wynder E: Breast cancer in black american women. Int J Cancer 24:541-544, 1979
11. Schatzkin A, Palmer JR, et al: Risk factors for breast cancer in black women. J Natl Cancer Inst 78:213-217, 1987
12. Laing AE, Demenais FM, Williams R, et al: Breast cancer risk factors in African-American women: The Howard University tumor registry experience. J Natl Med Assoc 85:931-939, 1993
13. Mayberry R, Stoddard-Wright C: Breast cancer risk factors among black women and white women: similarities and differences. Am J Epidemiol 136: 1445-1456, 1992
14. Palmer J, Richard L, Harlap S, et al: Adult height and risk of breast cancer among US black women. Am J Epidemiol 141:845-849, 1995
15. Kelsey JL, Gammon MD, John EM: Reproductive factors and breast cancer. Epidemiol Rev 15:36-47, 1993
16. Helmrich SP, Shapiro S, et al: Risk factors for breast cancer. Am J Epidemiol 117:35-45, 1983
17. Stavraky K, Emmons S: Breast cancer in premenopausal and postmenopausal women. J Natl Cancer Inst 53:647-654, 1974
18. Paffenbarger RS, Kampert JB, Chang HG: Characteristics that predict risk of breast cancer before and after menopause. Am J Epidemiol 112:258-268, 1980
19. Bodian CA: Benign breast diseases, carcinoma in situ, and breast cancer risk. Epidemiol Rev 15:177-187, 1993
20. Kelsey JL: Breast cancer epidemiology: summary and future directions. Epidemiol Rev 15:256-263, 1993
21. Willett WC, Browne ML, et al: Relative weight and risk of breast cancer among premenopausal women. Am J Epidemiol 122:731-740, 1985
22. Newcomb PA, Storer BE, et al: Lactation and a reduced risk of premenopausal breast cancer. New Engl J Med 330:81-87, 1994
23. National Center for Health Statistics. Health and Nutritional Examination Survey I: epidemiologic follow-up study wave 1, 1982-1984. Vital Health Stat 1:22, 1987
24. Krieger N: Exposure, susceptibility, and breast cancer risk. Breast Cancer Res Treat 13:205-223, 1989
25. Finklea J, Priester F, Creason JP, et al: Polychlorinated biphenyl residues in human plasma expose a major urban pollution problem. Am J Pub Health 62:645-651, 1972
26. Kutz FW, Yobs AR, Strassman SC: Racial stratification of organochlorine insecticide residues in human adipose tissue. J Occup Med 19:619-622, 1977
27. Michels KB, Hsieh CC, Trichopoulos D, et al: Abortion and breast cancer risk in seven countries. Cancer Causes Control 6(1):75-82, 1995
28. Daling JR, Malone KE, Voigt LF, et al: Risk of breast cancer among young women: Relationship to induced abortion. J Natl Cancer Inst 86:1584-1592, 1994
29. Rosenberg L, Palmer JR, Kaufman DW, et al: Breast cancer in relation to the occurrence and time of induced and spontaneous abortion. Am J Epidemiol 127:981-989, 1988
30. Hadjimichael OC, Boyle CA, Meis J: Abortion before first live birth and risk of breast cancer. Br J Cancer 53:281-284, 1986
31. Pike MC, Henderson BE, Casagrande JT, et al: Oral contraceptive use and early abortion as risk factors for breast cancer in young women. Br J Cancer 43:72-76, 1981
32. Krieger N, Wolff MS, et al: Breast cancer and serum organochlorines: a prospective study among white, black and Asian women. J Natl Cancer Inst 86:589-599, 1994
33. Wolff MS: Occupationally derived chemicals in breast milk. Am J Ind Med 4:259-281, 1983
34. Wolff M, Toniolo PG, Lee EW, et al: Blood levels of organochlorine residues and risk of breast cancer. J Natl Cancer Inst 85:648-652, 1993
35. Ownby HE, Frederick J, Russo J, et al: Racial differences in breast cancer patients. J Natl Cancer Inst 75:55-60, 1985
36. Natarajan, Nachimuthu M, Takuma N, et al: Race-related differences in breast cancer patients: Results of the 1982 national survey of breast cancer by the American College of Surgeons. Cancer 56:1704-1709, 1985
37. Vernon S, Tilley C, et al: Ethnicity, survival and delay in seeking treatment for symptoms of breast cancer. Cancer 55:1563-1571, 1985
38. Dansey RD, Hessel P, Browde S, et al: Lack of a significant independent effect of race on survival in breast cancer. Cancer 61:1908-1912, 1988
39. Gordon N, Joseph C, et al: Socioeconomic factors and race in breast cancer recurrence and survival. Am J Epidemiol 135:609-618, 1992
40. Hunter C, Redmond C, et al: Breast cancer: Factors associated with stage at diagnosis in black and white women. J Natl Cancer Inst 85:1129-1137, 1993
41. Williams R, Laing A, et al: Descriptive analysis of breast cancer in African-American women at Howard University Hospital, 1960-1987. J Natl Med Assoc 85:828-834, 1993
42. Eley W, Hill HA, et al: Racial differences in survival from breast cancer: Results of the National Cancer Institute black/white survival study. JAMA 272:947-954, 1994
43. Elledge RM, Clark GM, et al: Tumor biologic factors and breast cancer prognosis among white, hispanic, and black women in the United States. J Natl Cancer Inst 86:705-712, 1994
44. Jones B, Kasl S, et al: Can mammography screening explain the race difference in stage at diagnosis of breast cancer? Cancer 75:2103-2113, 1995
45. Weiss S, Tartter P, et al: Ethnic difference in risk and prognostic factors for breast cancer. Cancer 76: 268-274, 1995
46. Chen VW, Correa P, et al: Histological characteristics of breast carcinoma in blacks and whites. Cancer Epidemiol Biomark Prev 3:127-135, 1994
47. Ansell D, Whitman S, Lipton R, Cooper R: Race income, and survival from breast cancer at two public hospitals. Cancer 72:2974-2978, 1993
48. Muss HB, Hunter CP, Wesley M, et al: Treatment plans for black and white women with stage II node-positive breast cancer. The National Cancer Institute black/white cancer survival study experience. Cancer 70:2460-2467, 1992
49. Roach M 3rd, Alexander M: The prognostic significance of race and survival from breast cancer: A model for assessing the reliability of reported survival differences. J Natl Med Assoc 87:214-219, 1995
50. Zaloznik A: Breast cancer stage at diagnosis: Caucasians versus Afro-Americans. Breast Cancer Res Treat 34:195-198, 1995
51. Trock B, Rimer BK, et al: Impact of an HMO-based intervention to increase mammography utilization. Cancer Epidemiol Biomark Prev 2:151-156, 1993
52. Kimmick G, Muss H, et al: A comparison of treatment outcomes for black patients and white patients with metastatic breast cancer. Cancer 67:2850-2854, 1991
53. Pierce L, Fowble B, et al: Conservative surgery and radiation therapy in black women with early stage breast cancer. Patterns of failure and analysis of outcome. Cancer 69:2831-2841, 1992
54. Mohla S, Sampson CC, Khan T, et al: Estrogen and progesterone receptors in breast cancer in Black Americans. Cancer 50:552-559, 1982
55. Valanis B, Wirman J, Hertzberg VS: Social and biological factors in relation to survival among black vs. white women with breast cancer. Breast Cancer Res Treat 9:135-143, 1987
56. Kovi J, Mohla S, et al: Breast lesions in black women. Pathol Annu 24:199-218, 1989
57. Shiao YH, Chen VW, Scheer WD, et al: Racial disparity in the association of p53 gene alterations with breast cancer survival. Cancer Res 55:1485-1490, 1995
58. Faust B, Johnson W, et al: Biracial comparisons of breast cancer among New Orleans females. In: Correa P, Johnson WD: An International Survey of Distributions of Histologic Types of Breast Cancers. UICC Technical Report Series 35, Geneva, 1978, pp 101-118
59. Mittra N, Rush BF Jr, Verner E: A comparative study of breast cancer in the black and white populations of two inner city hospitals. J Surg Oncol 15:11-17, 1980
60. Freeman H, Wasfie T: Cancer of the breast in poor black women. Cancer 63:2562-2569, 1989
61. Pegoraro RJ, Nirmul D, Reinach SG, et al: Breast cancer prognosis in three different racial groups in relation to steroid hormone receptor status. Breast Cancer Res Treat 7:111-118, 1986
62. Pegoraro RJ, Karnan V, Nirmul D, et al: Estrogen and progesterone receptors in breast cancer among women of different racial groups. Cancer Res 46: 2117-2120, 1986
63. Beverly LN, Flanders WD, Go RC, et al: A comparison of estrogen and progesterone receptors in black and white breast cancer patients. Am J Pub Health 77:351-353, 1987
64. Stanford J, Greenberg R: Breast cancer incidence in young women by estrogen receptor status and race. Am J Pub Health 79:71-73, 1989
65. Blaszyk H, Vaughn CB, et al: Novel pattern of p53 gene mutations in an American black cohort with high mortality from breast cancer. Lancet 343: 1195-1197, 1994
66. Trock BJ: Molecular epidemiology. In: Harris JR, Lippman ME, Morrow M, Hellman S (eds) Diseases of the Breast. JB Lippincott, Philadelphia, 1995, pp 213-220
67. Zambetti GP, Levine AJ: A comparison of the biological activities of wild-type and mutant p53. FASEB J 7:855-865, 1993
68. Dittmer D, Pati S, et al: Gain of function mutations in p53. Nature Genet 4:42-46, 1993
69. Wenger CR, Beardslee S, et al: DNA ploidy, S-phase, and steroid receptors in more than 127,000 breast cancer patients. Breast Cancer Res Treat 28: 9-20, 1993
70. Taioli E, Trachman J, et al: A CYP1A1 restriction fragment length polymorphism is associated with breast cancer in African-American women. Cancer Res 55:3757-3758, 1995
71. Coates RJ, Clark WS, et al: Race, nutritional status, and survival from breast cancer. J Natl Cancer Inst 82:1684-1692, 1990
72. Taioli E, Crofts F, et al: A specific African-American CYP1A1 polymorphism is associated with adenocarcinoma of the lung. Cancer Res 55:472-473, 1995
73. Evans WE, Relling MV, et al: Genetic basis for a lower prevalence of deficient CYP2D6 oxidative drug metabolism phenotypes in Black Americans. J Clin Invest 91:2150-2154, 1993
74. Weston A, Ling-Cawley HM, et al: Determination of the allelic frequencies of an L-myc and a p53 polymorphism in human lung cancer. Carcinogenesis 15: 583-587, 1994
75. Weston A, Vineis P, et al: Racial variation in the distribution of the Ha-ras-1 allele. Mol Carcinogen 4:265-268, 1991
76. Bell DA, Taylor JA, et al: Genotype/phenotype discordance for human arylamine N-acetyltransferase (NAT2) reveals a new slow-acetylator allele common in African-Americans. Carcinogenesis 14:1689-1692, 1993
77. Rothman N, Stewart WF, et al: Misclassification of genetic susceptibility biomarkers: implications for case-control studies and cross-population comparisons. Cancer Epidemiol Biomark Prev 2:299-303, 1993
78. Struewing JP, Abeliovich D, et al: The carrier frequency of the BRCA1 185delAG mutation is approximately 1 percent in Ashkenazi Jewish individuals. Nature Genet 11:198-200, 1995